California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on September 3, 2026

Sep. 3, 2026

MediaAlpha Announces Chief Financial Officer Transition

Indeterminate GlobeNewswire

Sep. 3, 2026

Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Skyworks to Present at the Goldman Sachs Communacopia and Technology Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Apriem Advisors Releases Fourth Quarter Market Outlook: Optimism Tempered by Election-Cycle Caution

Indeterminate GlobeNewswire

Sep. 3, 2026

Magnite Establishes Premier Destination for Verified Live Streaming Inventory

Indeterminate GlobeNewswire

Sep. 3, 2026

Quince Therapeutics to Participate in September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Biomea Fusion to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Enphase Energy Brings Smart EV Charging to More Homes Across Europe

Indeterminate GlobeNewswire

Sep. 3, 2026

Ondra Health Expands to Six Named GLP-1 Pharmacy Partners, Giving Patients More Choice

Indeterminate GlobeNewswire

Sep. 3, 2026

Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer

Indeterminate GlobeNewswire

Sep. 3, 2026

BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Gyre Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Ducommun to Participate in Gabelli Aerospace & Defense Symposium

Indeterminate GlobeNewswire

Sep. 3, 2026

Commure Ambient AI Achieves Class I Certification and MHRA Registration

Indeterminate GlobeNewswire

Sep. 3, 2026

Reborn Coffee Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements

Indeterminate GlobeNewswire